CLASS II Device recall · Reported 1 Jun 2016 · FDA Enforcement Report

Novocastra Liquid Mouse Monoclonal Antibody Calretinin recalled

Leica Microsystems is recalling Novocastra Liquid Mouse Monoclonal Antibody Calretinin, Ncl-l-calret-566, distributed in 10 states. The recall was initiated on 22 Mar 2016 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot numbers: 6025204, 6029060, 6029949, 6035923 and 6036060.
Quantity recalled290 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1704-2016
FDA event ID
73823
Recalling firm
Leica Microsystems, Buffalo Grove, IL
Classification
Class II
Status
Terminated
Recall initiated
22 Mar 2016
FDA classified
20 May 2016
Reported
1 Jun 2016
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

22 Mar 2016Recall initiated by company
20 May 2016Classified by FDA+59 days
1 Jun 2016Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Novocastra Liquid Mouse Monoclonal Antibody Calretinin when used in combination with specific Lots of antibody diluent will give reduced staining.

Product as listed by the FDA

Novocastra Liquid Mouse Monoclonal Antibody Calretinin, NCL-L-CALRET-566. Intended for the qualitative identification by light microscopy of human calretinin molecule in paraffin sections.

Where it was distributed

Worldwide Distribution -- U.S., to the following states: AK, CA, FL, GA, MN, MT, NJ, OH, TX and WA; and, the country of Canada.

AlaskaCaliforniaFloridaGeorgiaMinnesotaMontanaNew JerseyOhioTexasWashington

Questions about this recall

Why was it recalled?

Novocastra Liquid Mouse Monoclonal Antibody Calretinin when used in combination with specific Lots of antibody diluent will give reduced staining.

Which lots are affected?

Lot numbers: 6025204, 6029060, 6029949, 6035923 and 6036060.

Where was it sold?

Worldwide Distribution -- U.S., to the following states: AK, CA, FL, GA, MN, MT, NJ, OH, TX and WA; and, the country of Canada.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Leica Microsystems

All 40

Other Other Medical Devices recalls

All 13,884